What changes can a pharmacist make to a CII prescription after consulting the prescriber?

The ability of a pharmacist to make changes to a Schedule II (CII) prescription after consulting with the prescriber is governed by both federal and state regulations. In this context, the correct choice is focused on the modifications that can be made without compromising the integrity of the prescription or the patient’s safety.

When a pharmacist consults with the prescriber, they are permitted to make specific changes such as the drug quantity, strength, dosage form, and directions for use. These modifications are often necessary to ensure that the prescription meets the patient's therapeutic needs or to rectify minor discrepancies that do not alter the purpose of the prescription.

For instance, if a prescriber agrees to increase the quantity of the medication based on a patient's response to treatment or to change the dosage form for better compliance, these alterations are justifiable and can be made to the prescription. However, it's crucial that these changes are thoroughly discussed and confirmed with the prescriber to maintain the prescription's validity.

The other options represent aspects of a prescription that cannot typically be changed by a pharmacist, even after consultation. This includes the patient’s name, which is a critical identifier for both legal and safety reasons; the prescriber’s signature, as it validates the prescription; and the method of administration